Published in Dig Dis Sci on April 05, 2008
miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. EMBO Mol Med (2012) 1.54
Statins in primary biliary cirrhosis: are they safe? Dig Dis Sci (2009) 0.86
Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers. BMC Surg (2017) 0.75
Effects of statins on cholestasis: good, bad or indifferent? J Gastroenterol Hepatol (2011) 0.75
Primary biliary cirrhosis. N Engl J Med (2005) 7.59
Statins as a newly recognized type of immunomodulator. Nat Med (2000) 5.00
Current perspectives on statins. Circulation (2000) 3.83
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut (2002) 1.98
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology (2000) 1.88
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology (1985) 1.86
The true impact of fatigue in primary biliary cirrhosis: a population study. Gastroenterology (2002) 1.84
Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial. Gastroenterology (1999) 1.58
Incidence of statin hepatotoxicity in patients with hepatitis C. Clin Gastroenterol Hepatol (2006) 1.55
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project. Circulation (2002) 1.51
Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis. Am J Gastroenterol (1995) 1.43
The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis. Arch Pathol Lab Med (1998) 1.42
Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. J Hepatol (2007) 1.36
Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same? Drug Saf (2002) 1.24
Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology (1994) 1.21
Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort. Gut (2005) 1.17
Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol (2000) 1.13
Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology (1985) 1.11
Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? Hepatology (1992) 1.08
Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers. J Hepatol (2002) 1.04
A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J Hepatol (1992) 1.03
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut (2006) 1.01
Experience with statin use in patients with chronic hepatitis C infection. Am J Cardiol (2005) 0.99
Atorvastatin associated liver disease. Dig Liver Dis (2006) 0.98
Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review. Atherosclerosis (2007) 0.97
Hepatotoxicity of hypolipidemic drugs. Clin Liver Dis (2003) 0.93
Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol (2005) 0.89
Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease. Hepatology (2000) 0.83
Hypercholesterolemia in primary biliary cirrhosis is no risk factor for atherosclerosis. Dig Dis Sci (1993) 0.82
Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway. J Lipid Res (1998) 0.80
Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia. Clin Ther (1994) 0.79
Primary biliary cirrhosis. N Engl J Med (1997) 0.75
Lipoprotein abnormalities in patients with early primary biliary cirrhosis. Eur J Clin Invest (1984) 0.75
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med (2004) 16.21
The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology (2003) 3.87
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology (2007) 3.39
Adding emotional stressors to training in simulated cardiopulmonary arrest enhances participant performance. Med Educ (2010) 3.17
How time affects the risk of rupture in appendicitis. J Am Coll Surg (2006) 2.71
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
Multicenter, randomized, controlled trial of virtual-reality simulator training in acquisition of competency in colonoscopy. Gastrointest Endosc (2006) 2.33
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol (2008) 2.16
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT. Am J Gastroenterol (2004) 2.12
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08
Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin Gastroenterol Hepatol (2005) 1.79
The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol (2004) 1.74
Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol (2006) 1.69
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet (2010) 1.62
Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res (2004) 1.57
Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine. Clin Gastroenterol Hepatol (2008) 1.57
Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol (2004) 1.50
Optimizing selective cerebral perfusion: deleterious effects of high perfusion pressures. J Thorac Cardiovasc Surg (2008) 1.48
The fate of the distal aorta after repair of acute type A aortic dissection. J Thorac Cardiovasc Surg (2006) 1.47
Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int (2013) 1.43
Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center. Ann Thorac Surg (2004) 1.43
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet (2012) 1.32
Extubation in the operating room after congenital heart surgery in children. J Thorac Cardiovasc Surg (2008) 1.18
Composite aortic root replacement in acute type A dissection: time to rethink the indications? Eur J Cardiothorac Surg (2005) 1.12
Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma. Clin Cancer Res (2002) 1.10
Preoperative arterial pulse pressure has no apparent association with perioperative mortality after lower extremity arterial bypass. Anesth Analg (2011) 1.09
Predictive model for postoperative delirium in cardiac surgical patients. Semin Cardiothorac Vasc Anesth (2010) 1.08
Cholestatic liver injury associated with whey protein and creatine supplements. Semin Liver Dis (2008) 1.08
Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol (2008) 1.07
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05
T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun (2007) 1.03
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol (2007) 1.03
Inhaled nickel nanoparticles alter vascular reactivity in C57BL/6 mice. Inhal Toxicol (2010) 1.01
Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol (2009) 1.01
Transplantation trends in primary biliary cirrhosis. Clin Gastroenterol Hepatol (2007) 0.98
Measuring the collateral network pressure to minimize paraplegia risk in thoracoabdominal aneurysm resection. J Thorac Cardiovasc Surg (2010) 0.98
Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology (2004) 0.97
The Relationship of Stress and Coping Methods to Adolescent Marijuana Use. Subst Abus (2001) 0.96
The Bentall procedure: is it the gold standard? A series of 597 consecutive cases. J Thorac Cardiovasc Surg (2010) 0.95
Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology (2004) 0.95
Toll-like receptors and liver disease. Liver Int (2013) 0.92
Time and the risk of ruptured tubal pregnancy. Obstet Gynecol (2004) 0.92
Economic and safety implications of introducing fast tracking in congenital heart surgery. Circ Cardiovasc Qual Outcomes (2013) 0.92
Pathogenic role of environmental toxins in immune-mediated liver diseases. J Immunotoxicol (2008) 0.91
Long-term integrity of teflon felt-supported suture lines in aortic surgery. Ann Thorac Surg (2005) 0.91
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics (2011) 0.90
Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. J Autoimmun (2007) 0.90
Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol (2005) 0.89
Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy. Blood (2003) 0.87
The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis. Biochem J (2002) 0.85
Recent advances in the epidemiology of primary biliary cirrhosis. Clin Liver Dis (2008) 0.84
Methotrexate therapy for primary biliary cirrhosis. Am J Gastroenterol (2003) 0.84
Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis (2005) 0.84
Preservation of spinal cord function after extensive segmental artery sacrifice: regional variations in perfusion. Ann Thorac Surg (2007) 0.84
Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. Inflamm Bowel Dis (2013) 0.84
Avoidance of hemodilution during selective cerebral perfusion enhances neurobehavioral outcome in a survival porcine model. Eur J Cardiothorac Surg (2007) 0.83
Inadequate visualization and reporting of ventricular function from transthoracic echocardiography after cardiac surgery. J Cardiothorac Vasc Anesth (2009) 0.82
Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev Immunol (2002) 0.81
Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations. Cancer Cell Int (2013) 0.81
Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis C. Clin Res Hepatol Gastroenterol (2012) 0.81
Optimal pH strategy for selective cerebral perfusion. Eur J Cardiothorac Surg (2005) 0.80
Apoptosis and the liver: relation to autoimmunity and related conditions. Autoimmun Rev (2003) 0.80
Factors affecting the decision to defer endotracheal extubation after surgery for congenital heart disease: a prospective observational study. Anesth Analg (2011) 0.80
Immunohistochemical visualization of histone H1 phosphorylation in squamous intraepithelial lesions of the gynecologic tract. Hum Pathol (2003) 0.79
Indication for surgery, the revised cardiac risk index, and 1-year mortality. Ann Vasc Surg (2011) 0.79
An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant. Transplantation (2009) 0.78
Primary biliary cirrhosis: a Mount Sinai perspective. Mt Sinai J Med (2003) 0.78
Primary biliary cirrhosis: environmental risk factors. Dis Markers (2010) 0.78
The efficacy of post-cardiopulmonary bypass dosing of vancomycin in cardiac surgery. Semin Cardiothorac Vasc Anesth (2010) 0.78
Vaccination as a triggering event for autoimmune hepatitis. Semin Liver Dis (2009) 0.78
Update on the epidemiology of primary biliary cirrhosis. Expert Rev Gastroenterol Hepatol (2011) 0.77
Maternal allergy acts synergistically with cigarette smoke exposure during pregnancy to induce hepatic fibrosis in adult male offspring. J Immunotoxicol (2011) 0.77
Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: a possible mechanism to explain the response to antiviral therapy. Liver Transpl (2005) 0.76
Perfusing the cold brain: optimal neuroprotection for aortic surgery. Ann Thorac Surg (2007) 0.76
Catalase and estradiol inhibit mitochondrial protein S-glutathionylation. Mol Cell Biochem (2012) 0.76
Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatol Res (2009) 0.75
Subarachnoid small-dose bupivacaine versus lidocaine for cervical cerclage. Anesth Analg (2003) 0.75
Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates. Dig Dis Sci (2013) 0.75
Diabetes and evidence of atherosclerosis are major risk factors for adverse outcome after elective thoracic aortic surgery. J Thorac Cardiovasc Surg (2003) 0.75
Antifibrinolytic use and bleeding during surgery on the descending thoracic aorta: a multivariate analysis. J Cardiothorac Vasc Anesth (2005) 0.75
Early extubation in adults undergoing surgery for congenital heart disease. J Cardiothorac Vasc Anesth (2012) 0.75
The influence of simulation-based physiology labs taught by anesthesiologists on the attitudes of first-year medical students towards anesthesiology. Middle East J Anaesthesiol (2011) 0.75